Friday, July 31, 2026

CG Bio’s EasyMade TI: The First Custom Titanium Implant Approved by FDA 510(k) – What It Means for Patients

CG Bio's EasyMade TI titanium implant receives FDA 510(k) approval, marking a milestone for customized implants in the U.S. market.

From Stocks to Demand: Samyang Foods on a Steady High in the Global Market

Samyang Foods, boosted by the global popularity...

North Korea Lashes Out at U.S.-South Korea Drills, Promises Strong Response

North Korea condemns U.S.-South Korea military drills as provocative, vowing to strengthen its nuclear capabilities in response.

Tag: Byooviz

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.